Catalyst Screening to Continuous Processing
PAT and Data Rich Experimentation for Continuous Processes
Programme
- Use of HTE for catalyst screening
- Scale-up of chosen catalyst into batch hydrogenation
- Design of continuous hydrogenation based off the batch screening results
Darren Whitaker of Takeda discusses the development of a continuous hydrogenation process, including catalyst screening, process optimization, and the use of process analytical technology (PAT) for real-time monitoring. Explore the importance of data-rich experimentation and model predictive control using advanced control algorithms to maintain optimal process conditions and ensure consistent product quality.
Target audience
Small molecule process development chemists and engineers
About the Presenter
Darren Whitaker
Associate Director, SMPD - Takeda Pharmaceuticals
Leads a small team within the process engineering group of Small Molecule Process Development. The team focuses on the application of advanced processing technologies and control algorithms within process development activities.
